IL1B and metabolic syndrome: According to the results of Montero et al., the combination of periodontal therapy with antibiotic therapy can have a positive effect on systemic inflammation (reflected in CRP, TNF-α, IL-1β levels) in patients with metabolic syndrome and periodontal disease.